Nomura Asset Management International’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Nomura Asset Management International's MRNA Position: Q2 2026 in Review
Nomura Asset Management International increased its Moderna (MRNA) stake by 3.7% in Q2 2026, buying an estimated $37K and bringing the position to 20,000 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1152.
Nomura Asset Management International first reported a position in MRNA in Q4 2025 and has held it in 3 quarters since. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Nomura Asset Management International held 20,000 shares of Moderna worth $1.4M as of Q2 2026.
- Nomura Asset Management International bought 716 Moderna shares in Q2 2026, an estimated $37K.
- Moderna made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1152 holding.
- Nomura Asset Management International first reported a position in Moderna in Q4 2025 and has held it in 3 quarters since.
- 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.